WATSON 583 (Propafenone 225 MG)
Pill imprint WATSON 583 has been identified as Propafenone hydrochloride 225 MG.
Propafenone is used in the treatment of atrial fibrillation; wolff-parkinson-white syndrome; atrial flutter; ventricular tachycardia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 225 MG is not a controlled substance under the Controlled Substance Act (CSA).
- WATSON 583
- 225 MG
- 10.00 mm
- Prescription only
- Drug Class:
- Group I antiarrhythmics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|63739-0510||McKesson Packaging Services|
|54569-6133||A-S Medication Solutions, LLC (repackager)|
Note: Inactive ingredients may vary.
More about propafenone
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.